chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Migraine, Pain in extremity, Vision blurred
Clinical narrative: Migraine headache with blurred vision; Migraine headache with blurred vision; Sore arm; Fatigue; Dizzyness; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 12Mar2021, at 15:30 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included atenolol (MANUFACTURER UNKNOWN), diphenhydramine (MANUFACTURER UNKNOWN) and famotidine (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 20Feb2021, at 11:00 as a single dose for COVID-19 immunisation. On 13Mar2021, at 09:00 the patient experienced migraine headache with blurred vision, sore arm, fatigue and dizziness. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events migraine headache with blurred vision, sore arm, fatigue and dizziness were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Muscle twitching, Musculoskeletal stiffness, Neck pain, Tremor
Clinical narrative: Very sore, stiff neck hot to the touch; Very sore, stiff neck hot to the touch; Very sore, stiff neck hot to the touch; Body twitches; Tremors; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 10Mar2021 at 14:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included protein S deficiency. The patient had latex allergy and shellfish allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included AMLODIPINE, ASPIRIN, FLONASE, and PANTOPRAZOLE, all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received iodine and had drug allergy. On 11Mar2021 at 15:45, the patient experienced very sore, stiff neck hot to the touch, body twitches and tremors. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether the therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very sore, stiff neck hot to the touch, body twitches and tremors was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Severe diarrhea; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration on 11Mar2021 at 13:00 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, allergy to latex and adhesive. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications taken within two weeks of vaccination were not reported. The patient previously received capsaicin (MANUFACTURER UNKNOWN) for unknown indication and experienced drug allergy. On 12Mar2021 at 16:00, the patient experienced severe diarrhea. Therapeutic measure was not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe diarrhea was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Left arm sore at the needle site and the site muscle feels tight like a ball and still hurts after 2 days; This is a spontaneous report from a non-contactable consumer, the patient. A 73-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 12Mar2021 at 15:00 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID19, blood pressure high and cholesterol high. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 12Mar2021 at 18:00, the patient experienced left arm sore at the needle site and the site muscle feels tight like a ball and still hurts after 2 days. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event left arm sore at the needle site and the site muscle feels tight like a ball and still hurts after 2 days was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen glands in armpit of the arm where I received the injection; This is a spontaneous report from a non-contactable consumer, the patient. A 59-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 11Mar2021 at 12:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. The patient previously received clindamycin (MANUFACTURER UNKNOWN) on an unspecified date, for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Mar2021, the patient experienced swollen glands in armpit of the arm where she had received the injection. Injection was on Thursday and swollen gland felt on Saturday. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen glands in armpit of the arm where the patient received the injection was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Migraine, Nausea
Clinical narrative: Migraine; nausea; headache; exhaustion; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Mar2021, at 15:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, obesity and penicillin allergy. It was unknown if the patient was pregnant. Concomitant medications included albuterol (MANUFACTURER UNKNOWN); formoterol fumarate/ mometasone furoate (DULERA) and sertraline hydrochloride (ZOLOFT); all for unknown indications from unknown dates and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Mar2021, the patient experienced migraine, nausea, headache and exhaustion. The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events migraine, nausea, headache and exhaustion was recovered on 14Mar2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Glossodynia, Paraesthesia
Clinical narrative: Tongue sensitivity with hot and cold liquids; Tingling sensation all the time; This is a spontaneous report from a contactable healthcare professional. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ek9231) via intramuscular route of administration in the left arm on 05Jan2021 at 13:15 (at the age of 56-years-old) and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: el9262) via intramuscular route of administration in the left arm on 28Jan2021 at 10:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 08Jan2021 at 08:00, the patient experienced tongue sensitivity with hot and cold liquids and tingling sensation all the time. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tongue sensitivity with hot and cold liquids and tingling sensation all the time was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Rash papular, Throat irritation, Vaccination site pruritus
Clinical narrative: Itchy throat within hours. Still occurring 3 days post injection.; Sore left arm within hours of injection.; 3 days post injection the surrounding area of site is now itchy; 3 days post injection the surrounding area of site is now itchy with a red bumpy rash.; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 11Mar2021 at 09:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient's medical history reported was not applicable. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Mar2021 at 16:00 the patient experienced itchy throat within hours, still occurring 3 days post injection, sore left arm within hours of injection, 3 days post injection the surrounding area of site was itchy with a red bumpy rash. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events itchy throat within hours, still occurring 3 days post injection, sore left arm within hours of injection, 3 days post injection the surrounding area of site was itchy with a red bumpy rash was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Muscle tightness
Clinical narrative: Dizziness upon waking the next morning.; Muscle tension on left side of neck and jaw; Mild headache; This is a spontaneous report from a contactable healthcare professional. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the arm left on 13Mar2021 at 15:00 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient has received any medication within two weeks of vaccination. On 13Mar2021 at 15:30, the patient experienced muscle tension on left side of neck and jaw and mild headache beginning 30 minutes after dose. On 14Mar2021, the patient experienced dizziness upon waking the next morning. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events muscle tension on left side of neck and jaw, mild headache and dizziness was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Flu like symptoms; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6206) via an unspecified route of administration on 10Mar2021 at 12:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Mar2021, the patient experienced flu like symptoms. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event flu like symptoms was resolved on an unknown date in Mar2021.   No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Eye irritation, Fatigue, Headache, Oropharyngeal pain, Pain
Clinical narrative: Headache; Burning eyes; Slight sore throat; Achy; Tired; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Mar2021 at 09:00 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol and overweight. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included rosuvastatin calcium (CRESTOR) from an unknown date for an unknown indication and was unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Feb2021 at 10:00 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. On 14Mar2021 at 10:00, the patient experienced headache, burning eyes, slight sore throat, achy and tired. The events did not result in doctor or other healthcare professional office/clinic visits, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, burning eyes, slight sore throat, achy and tired was not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue
Clinical narrative: Chills; Weakness; Tired; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 12Mar2021 at 14:45 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. On 13Mar2021 at 22:00, the patient experienced chills, weakness and tired. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, weakness and tired were resolved on an unknown date in Mar2021.   No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache
Clinical narrative: Tiredness; Dizziness; Headache; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 11Mar2021 at 09:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The medical history were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The concomitant medications included losartan (MANUFACTURER UNKNOWN), bupropion hydrochloride (WELLBUTRIN), omeprazole (MANUFACTURER UNKNOWN), chlorphenamine maleate (ALLER-CHLOR) and atorvastatin calcium (LIPITOR), all from unknown dates for unknown indications and unknown if ongoing. On 11Mar2021 at 11:30, the patient experienced tiredness, dizziness and headache. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as the result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tiredness, dizziness and headache was recovering at the time of this report.    No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Pain in extremity
Clinical narrative: Severe long lasting pain in arm,; difficult to move; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration on 11Mar2021 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021 the patient experienced severe long lasting pain in arm and difficult to move even after almost 3 days. Since the vaccination, the patient has not been tested for COVID-19. The clinical outcome of the events severe long lasting pain in arm and difficult to move was unknown at the time of report.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenitis, Pain, Swelling
Clinical narrative: "My" let armpit swelled up and has been painful for 4days and counting; "My" let armpit swelled up and has been painful for 4 days and counting; It hurts to put "my" arm down and "I" can only keep it up; The Lymph Nodes in left arm are inflamed; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on an unknown date in Mar2021 at 13:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The medical history included latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. The patient received unspecified birth control drug within two weeks of vaccination. On 05Mar2021 at 01:00, the patient's left armpit swelled up and was painful for 4 days and counting. It hurts to put arm down and could only keep it up and the lymph nodes in left arm are inflamed. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event left armpit painful was recovered on 09Mar2021, while the clinical outcome of the events left armpit swelled up, lymph nodes in left arm are inflamed and hurts to put arm down and could only keep it up were recovering at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Feel nauseous during the night of March 5,2021. From that time until last week, could not keep anything down including water. Able to eat one meal a day but still feel nauseous every morning until early afternoon.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the right arm on 04Mar2021 at 15:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included congestive heart failure, chronic kidney disease, asthma, fibromyalgia, arthritis and known allergy to latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN), furosemide (MANUFACTURER UNKNOWN) and metoprolol succinate (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received oxycodone (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication and experienced drug allergy. On 05Mar2021 at 20:00, the patient began to feel nauseous during the night. From that time until last week before this report, the patient could not keep anything down including water. The patient was then able to eat one meal a day but she still felt nauseous every morning until early afternoon at the time of this report. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event began to feel nauseous during the night and could not keep anything down including water, the patient was then able to eat one meal a day was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Fatigue, Pain in extremity
Clinical narrative: Confusion and repeating "myself"; jumbled images in "my" head; Sore arm; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Mar2021 at 17:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 07Mar2021 at 00:00, the patient experienced sore arm and fatigue. On 08Mar2021, the patient experienced confusion, repeating himself and jumbled images in the head. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore arm, fatigue, confusion, repeating himself and jumbled images in the head was resolved with sequelae.    No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: This is a spontaneous report from a noncontactable consumer (patient). A 19-year-old (non-pregnant) female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 19, via an unspecified route of administration, on Mar 12, 2021, at 04:45, single dose, for COVID-19 immunisation. No medical history or concomitant medications reported. No known allergies to medications, food or other products. Prior to vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine.  On Mar 14, 2021, patient experienced sore throat. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures taken as a result of the reported event. Since the vaccination, patient has not tested for COVID-19. The outcome of sore throat: recovering (at the time of this report). No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Head discomfort, Hypoaesthesia
Clinical narrative: Numbness in head; Pressure in head; This is a spontaneous report from a contactable other healthcare professional. A 39-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 15Mar2021 at 10:45 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Mar2021 at 16:00, the patient experienced numbness in head and pressure in the head and lot of pressure in the head. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as result of the events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the events numbness in head and a lot of pressure in head was unknown at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is excepted.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Hot flush, Nausea, Pain in extremity, Somnolence
Clinical narrative: just a little sleepy; Woke up with extreme nausea; My arm felt like Id been stung by a hornet (throbbing, very painful, no change in appearance), 6am every thing was fine again, just flu shot type arm pain- very quickly got better over the course of about half an hour; Hot & cold flashes (not my typical fever feeling); At 01:30  shot received,  17:30  it felt like I had a flu shot; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 04Mar2021 at 13:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included gastroesophageal reflux disease (GERD). The patient had no known allergies to medications, food or other products. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN) and unspecified multivitamin; all from an unknown date for unknown indication and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. At 01:30,  the shot was received and at 17:30, she felt like she had a flu shot. On 05Mar2021 at 02:30, the patient woke up with extreme nausea, her arm felt like she had been stung by a hornet (throbbing, very painful, no change in appearance) and hot & cold flashes (not her typical fever feeling). At 06:00, everything was fine again, just flu shot type arm pain- very quickly got better over the course of about half an hour and at 09:00, her arm was barely noticeable and she can move it just fine. Overall she felt great- just a little sleepy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events woke up with extreme nausea, at 01:30 shot received, 17:30  it felt like had a flu shot and hot & cold flashes (not my typical fever feeling) was recovered on 05Mar2021 at 06:00. The clinical outcome of the events arm felt like I had been stung by a hornet (throbbing, very painful, no change in appearance), 6am every thing was fine again, just flu shot type arm pain- very quickly got better over the course of about half an hour was resolved on 05Mar2021 at 09:00. The clinical outcome of the event just a little sleepy was unknown at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain
Clinical narrative: Sore to firm touch under left arm pit.; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En615906121) via an unspecified route of administration in the left arm on 26Feb2021 at 18:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medication included vitamins (MANUFACTURER UNKNOWN) and herbs (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously took codeine (MANUFACTURER UNKNOWN) and erythromycin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 27Feb2021 at 09:00, the patient experienced sore to firm touch under left arm pit. 17 days after the first dose the patient had sore. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore to firm touch under left arm pit. was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 78-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6204) via an unspecified route of administration in the left arm on 04Mar2021 at 14:30 (at the age of 78-years-old) as a single dose for COVID-19 immunisation. Medical history included osteoporosis. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included LIPITOR from an unknown date for an unknown indication and unknown if ongoing. On 04Mar2021 at 21:30, the patient experienced severe dizziness which lasted 7 hours. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event dizziness was recovered on 05Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Loose Stools- similar to IBS or lactose intolerance. Can't narrow down to only dairy though.; This is a spontaneous report from a non-contactable nurse. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EJ1685) via an unspecified route of administration in the arm right on 08Jan2021 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The medical history included sulfa allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included ZYRTEC, CELEXA, and WELLBUTRIN, all from unknown dates for unknown indications and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 22Jan2021, the patient experienced loose stools which was similar to irritable bowel syndrome (IBS) or lactose intolerance. The patient reported that she could not narrow down to only dairy though. The adverse event did not result in doctor or other healthcare professional office/clinic and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event loose stools was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Electric shock sensation
Clinical narrative: Electricity in my legs; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 10Mar2021 at 14:30 (at the age of 75-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN), vitamin d nos (VIT D) and zinc (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Mar2021 at 09:00, the patient experienced electricity in legs. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event electricity in legs was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Musculoskeletal stiffness, Pain
Clinical narrative: Friday: tired, achy, headache & stiff neck; Friday: tired, achy, headache & stiff neck; Friday: tired, achy, headache & stiff neck; low grade headache started 1 hr after injection and stayed with "me" the rest of the day/ Friday: headache; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 11Mar2021 at 12:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The medical history included diabetes and seasonal allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received varicella zoster vaccine rge (cho) (SHINGRIX) on 15Feb2021 within four weeks prior to the vaccination. The concomitant medications included metformin (MANUFACTURER UNKNOWN), atorvastatin calcium (LIPITOR), estrogens conjugated/medroxyprogesterone acetate (PREMPRO), estrogens conjugated (PREMARIN) and fluticasone propionate (ALLER FLO), all for  unknown indications from unknown dates and unknown if ongoing. On 11Mar2021 at 13:30, 1 hour after the vaccination, the patient experienced low grade headache and stayed with her the rest of the day. On 12Mar2021 at 13:30 Friday, the patient experienced tired, achy, headache and stiff neck. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events low grade headache, tired, achy, headache and stiff neck was resolved on a known date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Lymphadenopathy, Malaise, Nausea
Clinical narrative: Lymph node under arm blew up Monday in the arm that injection was in; Felt chills; Sick to stomach; Tired; Malaise; Injection site sore; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Mar2021 at 11:45 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 14Mar2021 at 11:00, the patient felt chills, sick to stomach, tired, malaise and injection site sore. On 15Mar2021, the lymph node under arm blew up on Monday in the arm that injection was in. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt chills, sick to stomach, tired, malaise, injection site sore, lymph node under arm blew up on Monday in the arm that injection was in was recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Lymph node under arm blew up Monday in the arm that injection was in; Felt chills; Sick to stomach; Tired; Malaise; Injection site sore; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Mar2021 at 11:45 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 14Mar2021 at 11:00, the patient felt chills, sick to stomach, tired, malaise and injection site sore. On 15Mar2021, the lymph node under arm blew up on Monday in the arm that injection was in. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt chills, sick to stomach, tired, malaise, injection site sore, lymph node under arm blew up on Monday in the arm that injection was in was recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 35.0
Sex: U
Vaccine: COVID19
Symptoms: Breast pain
Clinical narrative: After 2nd dose in left arm, felt burning in left side of left breast for a few days 1-2 weeks after vaccination date. Burning sensation lasted about a few hours each time.; This is a spontaneous report from a contactable healthcare professional, the patient. A 35-year-old unspecified gender patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9264) via an unspecified route of administration in the left arm on 23Feb2021 at 09:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder (ADHD). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included amfetamine aspartate/amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate (ADDERALL) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration on 02Feb2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. On an unknown date in 2021, after 2nd dose in left arm, the patient felt burning in left side of left breast for a few days 1-2 weeks after vaccination date, burning sensation lasted about a few hours each time. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event felt burning in left side of left breast for a few days 1-2 weeks after vaccination date was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dysuria, Fatigue, Gastrointestinal pain
Clinical narrative: Tiredness; Chills; GI tract cramps; Moderate pain during urination.; This is a spontaneous report from a non-contactable consumer, the patient. A 76-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration on 10Mar2021 (at the age of 76-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration on 17Feb2021 (at the age of 76-year-old) as a single dose for COVID-19 immunisation. On 10Mar2021, the patient experienced tiredness, chills, GI tract cramps and moderate pain during urination. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tiredness, chills, GI tract cramps and moderate pain during urination was resolved on an unknown date in Mar2021.  No follow-up attempts are possible. No further information is expected.